Surgical Site Infection Clinical Trial
Official title:
Effectiveness in Preventing Surgical Site Infection by Using Prophylactic Occlusive Ionic Silver-containing Dressing in Abdominal Colorectal Surgery Patients - Randomized Controlled Trial
Background: Ionic silver-containing dressing has been proven as a broad spectrum
antimicrobial agent to reduce inflammation of wounds and promote healing. However, surgical
incisions are usually dressed with conventional gauze dressing in colorectal surgery.
Objective: To compare the effectiveness in preventing surgical site infection (SSI) by using
conventional gauze dressing and occlusive ionic silver-containing dressing.
Methods: This is a single-blind two-arm parallel randomized controlled trial on occlusive
ionic silver-containing dressing conducted in Surgery Department of Princess Margaret
Hospital. Two hundred patients who undergo emergency or elective abdominal colorectal surgery
will be recruited and randomly assigned to have the surgical incisional wound dressed with
conventional gauze dressing or occlusive ionic silver-containing dressing. Subjects will be
assessed for SSI on day 3, 15 and 30 after operation in a clinical visit followed by phone
interviews.
Background Surgical site infections According to a Clean Care is safer programme by World
Health Organization(WHO), the second most frequent and surveyed health care-associated
infections in high-income countries is surgical site infections (SSI). The highest SSI is the
colorectal surgery with 9.5% interlude per operations. SSI develop negative influence on
patient outcome, such as burden the morbidity, mortality and extra expenses to health care
system. The length of stay increased 9.7 days due to SSI in 2005 in USA, and more expenses
spend on the antibiotics and the advanced dressing materials. Patient suffered from SSI will
double the mortality rate in USA with increased cost and readmission for the treatment.
Modern dressing There are many different treatment and dressing options for health care
providers for wound care. The dressings with advanced technology become more popular in
recent days. Many studies show the importance of moist wound dressing to enhance the wound
healing process. It can provide a moist wound environment, absorb the excess exudate, move
away the microorganism and prevent their replication, and provide a barrier from the external
environment than the conventional gauze dressing. Besides, a recommendation from the UK's
National Institution for Health and Clinical Excellence (NICE) suggest that all surgical
incision wound should be dressed with low-adhesive dressing for at least 3-5 days after
operation. And a journal published in CINAHL Information System stated that the use of
dressing with moist wound healing effects can help to reduce the SSI rate by 50% that the
conventional gauze. On the other hand, there are studies commended that there are no
significant different in prevention of SSI with the use of moist wound dressing. Therefore,
it is a controversial issue on the effectiveness of preventing SSI by using moist wound
dressing versus conventional gauze dressing.
Ionic silver-containing dressing Ionic silver (Ag+), is an active state silver oxidized
biologically, is proved as a broad spectrum antimicrobial agent that is effective against
aerobic, anaerobic, Gram-negative and Gram-positive bacteria, as well as fungi, viruses, and
yeast with minimal development of bacterial resistance. Silver is used commonly in many
dressings for the antimicrobial effect. Silver containing dressing can reduce the
inflammation of wounds and promotes healing, since silver cations in the dressing can destroy
microorganism by inactivating bacterial enzymes, disrupting the functions of cell membrane
and binding the bacterial DNA/RNA to cause cell death and inhibiting cell replication.
Abdominal Colorectal surgery and ionic silver-containing dressing in Hong Kong In Hong Kong,
colorectal cancer is the commonest cancer, there were around 5000 new cases in 2014. And it
is the second leading cause of cancer deaths, in 2015, around colorectal cancer caused 2000
deaths. An unpublished internal audit carried out in surgical department in Princess Margaret
Hospital (PMH) in 2015 found that the day 30 post-operation SSI incidence among patients with
colorectal surgery using occlusive ionic silver-containing dressing (20%; 19/95) was
statistically lower than those using conventional gauze dressing (52.9%; 9/17) with p=0.012
(Table 1). Although the effect of using silver dressing to reduce SSI rate is controversial,
there are no formal study has been published locally. Therefore, it is meaningful to carry
out a randomized controlled trial (RCT) to prove the significance of silver dressing in
reduce SSI rate.
Objective To compare the SSI incidence among patients with abdominal colorectal surgery
patients using prophylactic occlusive ionic silver-containing dressing and conventional gauze
dressing.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04096885 -
The Inselspital Surgical Cohort Study
|
||
Terminated |
NCT03820648 -
Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT04067843 -
Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study
|
N/A | |
Terminated |
NCT04042077 -
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
|
Phase 3 | |
Completed |
NCT05841576 -
Anaesthetic Management Guided by COMET Measurements
|
N/A | |
Withdrawn |
NCT05338281 -
NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT
|
N/A | |
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT01697748 -
Prospective Study on Cesarean Wound Outcomes
|
N/A | |
Terminated |
NCT01789697 -
Text Message Study
|
N/A | |
Recruiting |
NCT05966961 -
Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
|
||
Recruiting |
NCT05077592 -
Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site Infections
|
Phase 4 | |
Recruiting |
NCT05502380 -
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
|
Phase 3 | |
Recruiting |
NCT05763602 -
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
|
Phase 4 | |
Recruiting |
NCT03221023 -
Intrawound Vancomycin Prophylaxis for Neural Stimulator
|
Phase 2/Phase 3 | |
Completed |
NCT03257202 -
Topical Treatment and Prevalence of P. Acnes
|
Phase 2 | |
Completed |
NCT06154720 -
Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
|
||
Not yet recruiting |
NCT06465901 -
A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI
|
N/A | |
Not yet recruiting |
NCT04820075 -
Efficacy of an Intervention to Improve the Preoperative Shower in Scheduled Surgery
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Not yet recruiting |
NCT04496180 -
Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy
|
N/A |